Krüppel-like factor 2, a novel immediate-early transcriptional factor, regulates IL-2 expression in T lymphocyte activation

Journal of Immunology

Volumn 175, Issue 5, 2005, Pages 3060-3066

  Wu, Jinghai ^a   Lingrel, Jerry B ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; KRUPPEL LIKE FACTOR 2; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; ARTICLE; BINDING SITE; CONSENSUS SEQUENCE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE INDUCTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION INITIATION;

EID: 23844457210     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.5.3060     Document Type: Article

References (35)

1. Weiss, A., and D. R. Littman. 1994. Signal transduction by lymphocyte antigen receptors. Cell 76: 263-274.
2. Taniguchi, T., and Y. Minami. 1993. The IL-2/IL-2 receptor system: a current overview. Cell 73: 5-8.
3. Skerka, C., E. L. Decker, and P. F. Zipfel. 1995. A regulatory element in the human interleukin 2 gene promoter is a binding site for the zinc finger proteins Sp1 and EGR-1. J. Biol. Chem. 270: 22500-22506.
4. Anderson, K. P., C. B. Kern, S. C. Crable, and J. B. Lingrel. 1995. Isolation of a gene encoding a functional zinc finger protein homologous to erythroid Kruppel-like factor: identification of a new multigene family. Mol. Cell. Biol. 15: 5957-5965.
5. Wani, M. A., M. D. Conkright, S. Jeffries, M. J. Hughes, and J. B. Lingrel. 1999. cDNA isolation, genomic structure, regulation, and chromosomal localization of human lung Kruppel-like factor. Genomics 60: 78-86.
6. Kuo, C. T., M. L. Veselits, K. P. Barton, M. M. Lu, C. Clendenin, and J. M. Leiden. 1997. The LKLF transcription factor is required for normal tunica media formation and blood vessel stabilization during murine embryogenesis. Genes Dev. 11: 2996-3006.
7. Wani, M. A., R. T. Means, Jr., and J. B. Lingrel. 1998. Loss of LKLF function results in embryonic lethality in mice. Transgenic Res. 7: 229-238.
8. Wani, M. A., S. E. Wert, and J. B. Lingrel. 1999. Lung Kruppel-like factor, a zinc finger transcription factor, is essential for normal lung development. J. Biol. Chem. 274: 21180-21185.
9. Huddleson, J., S. Srinivasan, N. Ahmad, and J. B. Lingrel. 2004. Fluid shear stress induces endothelial KLF2 gene expression through a defined promoter region. J. Biol. Chem. 385: 723-729.
10. SenBanerjee, S., Z. Lin, G. B. Atkins, D. M. Greif, R. M. Rao, A. Kumar, M. W. Feinberg, Z. Chen, D. I. Simon, F. W. Luscinskas, et al. 2004. KLF2 is a novel transcriptional regulator of endothelial proinflammatory activation. J. Exp. Med. 199: 1305-1315.
11. Kuo, C. T., M. L. Veselits, and J. M. Leiden. 1997. LKLF: A transcriptional regulator of single-positive T cell quiescence and survival. Science 277: 1986-1990.
12. Kuo, C. T., M. L. Veselits, and J. M. Leiden. 1997. LKLF and FasL expression: correction and clarification. Science 278: 788-789.
13. Buckley, A. F., C. T. Kuo, and J. M. Leiden. 2000. Transcription factor LKLF is sufficient to program T cell quiescence via a c-Myc-dependent pathway. Nat. Immunol. 2: 698-704.
14. WAF1/CIP1. Oncogene 23: 8088-8096.
15. Schober, S. L., C. T. Kuo, K. S. Schluns, L. Lefrancois, J. M. Leiden, and S. C. Jameson. 1999. Expression of the transcription factor lung Kruppel-like factor is regulated by cytokines and correlates with survival of memory T cells in vitro and in vivo. J. Immunol. 163: 3662-3667.
16. Gebert, B., W. Fischer, E. Weiss, R. Hoffmann, and R. Haas. 2003. Hdicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science 301: 1099-1012.
17. Wu, J., A. Utani, H. Endo, and H. Shinkai. 2001. Deficiency of the decorin core protein in the variant form of Ehlers-Danlos syndrome with chronic skin ulcer. J. Dermatol. Sci. 27: 95-103.
18. Tzachanis, D., G. J. Freeman, N. Hirano, A. A. van Puijenbroek, M. W. Delfs, A. Berezovskaya, L. M. Nadler, and V. A. Boussiotis. 2001. Tob is a negative regulator of activation that is expressed in anergic and quiescent T cells. Nat. Immunol. 2: 1174-1182.
19. Hedin, K. E., M. P. Bell, K. R. Kalli, C. J. Huntoon, B. M. Sharp, and D. J. McKean. 1997. δ-Opioid receptors expressed by Jurkat T cells enhance IL-2 secretion by increasing AP-1 complexes and activity of the NF-AT/AP-1-binding promoter element. J. Immunol. 159: 5431-5440.
20. Kalli, K., C. Huntoon, M. Bell, and D. J. McKean. 1998. Mechanism responsible for T-cell antigen receptor- and CD28- or interleukin 1 (IL-1) receptor-initiated regulation of IL-2 gene expression by NF-κB. Mol. Cell. Biol. 18: 3140-3148.
21. Yingling, J. M., M. B. Datto, C. Wong, J. P. Frederick, N. T. Liberati, and X. F. Wang. 1997. Tumor suppressor Smad4 is a transforming growth factor β-inducible DNA binding protein. Mol. Cell. Biol. 17: 7019-7028.
22. Weiss, A., J. Imboden, D. Shoback, and J. Stobo. 1984. Role of T3 surface molecules in human T-cell activation: T3-dependent activation results in an increase in cytoplasmic free calcium. Proc. Natl. Acad. Sci. USA 81: 4169-4173.
23. Ahmad, N., and J. B. Lingrel. 2005. Kruppel-like factor2 transcriptional regulation involves heterogeneous nuclear ribonucleoproteins and acetyltransferases. Biochemistry 44: 6276-6285.
24. Jenkins, M. K., C. A. Chen, G. Jung, D. L. Mueller, and R. H. Schwartz. 1990. Inhibition of antigen-specific proliferation of type 1 murine T cell clones after stimulation with immobilized anti-CD3 monoclonal antibody. J. Immunol. 144: 16-22.
25. Sosinowski, T., A. Pandey, V. M. Dixit, and A. Weiss. 2000. Src-like adaptor protein (SLAP) is a negative regulator of T cell receptor signaling. J. Exp. Med. 191: 463-474.
26. Jenkins, M. K., A. Khoruts, E. Ingulli, D. L. Mueller, S. J. McSorley, R. L. Reinhardt, A. Itano, and K. A. Pape. 2001. In vivo activation of antigen-specific CD4 T cells. Annu. Rev. Immunol. 19: 23-45.
27. Schwartz, R. H. 2003. T cell anergy. Annu. Rev. Immunol. 21: 305-334.
28. Zhang, X., S. V. Srinivasan, and J. B. Lingrel. 2004. WWP1-dependent ubiquitination and degradation of the lung Kruppel-like factor, KLF2. Biochem. Biophys. Res. Commun. 316: 139-148.
29. Abraham, R. T., and A. Weiss. 2004. Jurkat T cells and development of the T-cell receptor signalling paradigm. Nat. Rev. Immunol. 4: 301-308.
30. Crabtree, G. R. 1989. Contingent genetic regulatory events in T lymphocyte activation. Science 243: 355-361.
31. Hughes, C. C., C. O. Savage, and J. S. Pober. 1990. Endothelial cells augment T cell interleukin 2 production by a contact-dependent mechanism involving CD2/LFA-3 interaction. J. Exp. Med. 171: 1453-1467.
32. Shaw, J. P., P. J. Utz, D. B. Durand, J. J. Toole, E. A. Emmel, and G. R. Crabtree. 1988. Identification of a putative regulator of early T cell activation genes. Science 241: 202-205.
33. Chen, W. V., J. Delrow, P. D. Corrin, J. P. Frazier, and P. Soriano. 2004. Identification and validation of PDGF transcriptional targets by microarray-coupled gene-trap mutagenesis. Nat. Genet. 36: 304-312.
34. Durand, D. B., J. P. Shaw, M. R. Bush, R. E. Replogle, R. Belagaje, and G. R. Crabtree. 1988. Characterization of antigen receptor response elements within the interleukin-2 enhancer. Mol. Cell. Biol. 8: 1715-1724.
35. Krummrei, U., E. E. Baulieu, and B. Chambraud. 2003. The FKBP-associated protein FAP48 is an antiproliferative molecule and a player in T cell activation that increases IL2 synthesis. Proc. Natl. Acad. Sci. USA 100: 2444-2449.